Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q2 2026 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2026-08-04

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 4, 2026

Total Value: $177M (100.0% shares, 0.0% debt)

Holdings (3)

Exited Positions (1)

CNTA CENTESSA PHARMACEUTICALS PLC 446.9%

Value $793M Shares 19,963,157 Est. Cost $20.88 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$793M	446.9%	$20.88	—	—	152309100

Decreased Positions (1)

NAMS NEWAMSTERDAM PHARMA COMPANY 42.2%

Value $74.85M (-12.6%) Shares 2,208,639 (-17.4%) Est. Cost $10.96 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,208,639 (-17.4%)	$74.85M (-12.6%)	42.2%	$10.96	—	ORDINARY SHARES	N62509109

Unchanged Positions (2)

PHAT PHATHOM PHARMACEUTICALS INC 45.6%

Value $80.99M Shares 7,464,572 Est. Cost $13.72 Unrealized —

AURA AURA BIOSCIENCES INC 12.2%

Value $21.58M Shares 3,039,892 Est. Cost $17.87 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PHAT	PHATHOM PHARMACEUTICALS INC	7,464,572	$80.99M	45.6%	$13.72	—	COM	71722W107
AURA	AURA BIOSCIENCES INC	3,039,892	$21.58M	12.2%	$17.87	—	COM	05153U107